Analysis RSV is the most common
reason of respiratory
inflammation in children
under 2 years old, and
bronchiolitis is the primary
cause of hospital admission
during the first year of birth,
with hospital admission
highest at age 2. A
multicenter, selective, double-
blind, regulated, clinical study
has proven the safety and
effective potential of
palivizumab.
SPSS18.0 statistical
software, Kolmogorov-
Smirnov
Method, Shapiro-Wilk
method, Chisquare test
have been used to analyse
the test results.
Stata
Version 8.0 program, χ2
Test, unpaired t test have
been used to analyse the
test results.
SPSS statistical software
version 16, Chi-square
test and student t-test
have been used to
analyse the test results.
Key Findings Studies show that 30%-40% of
infants previously admitted
due to bronchiolitis struggle
with asthma and also use anti-
asthma medicines. Studies
show that when palivizumab
was provided to healthy
babies, the number of days
with bronchospasm during the
first year of childhood did
decrease by 61 percent, thus
promoting the theory of direct
damage done by the virus.
The normalization of Zinc
levels with Zinc
Supplements could not
enhance the clinical results
of infants who were
admitted due to
pneumonia. Zinc deficit is
normal in children with
moderate to
severe pneumonia.
Physical chest exercise
showed several number
of improvements in
the pneumonia
hospitalized pediatrics.
The multifaceted
infection and prevention
of the VAP kit decreased
the risk of VAP and the
stay period in NICU.
Recommendations Strict compliance to infection-
control procedures is critical
for reducing the spreading of
RSV and may be affective in
the prevention of pulmonary
virus epidemics.
For infants with a zinc
deficit, zinc treatment can
improve the serum zinc
level to average.
In the treatment
of children who
are hospitalized with
pneumonia, the
paper suggests the
introduction of the chest
physiotherapy program.
VAP prevention bundle
is a combination of
several strategies and it
has been recommended
to other NICU’s.
Explanation of How
the Article Supports
EBP/Capstone
Project
The following article will
reflect upon the Capstone
project as the project is related
to respiratory disorder.
The following article will
reflect upon the Capstone
project as the project is
related to pneumonia.
The following article
will reflect upon the
Capstone project as the
project is related to
pneumonia.
The following article will
reflect upon the Capstone
project as the project is
related to pneumonia.
Criteria Article 5 Article 6 Article 7 Article 8
Author, Journal
(Peer-Reviewed),
and
Permalink or
Working Link to
Access Article
Mannan, M. A., Nahar, N.,
Ahmed, F., Jahan, I., Mosleh,
T., Khan, K. A., ... &
Shahidullah, M. (2018).
Neonatal Pneumonia in NICU
of a Tertiary Care Center.
Bangladesh Journal of Child
Health, 42(3), 112-117.
Yang, Z., Xiao, X., Huang,
Y., He, X., Lu, Q., Chen, S.,
& Lin, Z. (2017). Effects
and mechanisms of
ambroxol inhalation
(Mucosolvan®) in the
treatment of neonatal
pneumonia. Die Pharmazie-
An International Journal of
Pharmaceutical Sciences,
72(10), 604-607.
Li, B., Han, S., Liu, F.,
Kang, L., & Xv, C.
(2017). Budesonide
nebulization in the
treatment of neonatal
ventilator associated
pneumonia. Pakistan
journal of medical
sciences, 33(4), 997.
Min, L. U., & Tan, J.
(2017). Clinical efficacy
of ambroxol combined
with budesonide aerosol
inhalation in treating
neonatal pneumonia.
Chinese Journal of
Biochemical
Pharmaceutics, 37(3),
237-239.
Article Title and Neonatal Pneumonia in NICU Effects and mechanisms of Budesonide Nebulization Clinical efficacy of
© 2017. Grand Canyon University. All Rights Reserved.

The Prevention of Neonatal Respiratory Diseases in the Nicu

Contribute Materials

Related Documents

Overview of neonatal respiratory distress

+13062052269

info@desklib.com